SMITH & NEPHEW PLC |
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 1,038 GBX | +0.34% |
|
+4.81% | -3.76% |
| 05/06 | UBS Upgrades Smith & Nephew to Buy from Neutral, Raises PT | MT |
| 05/06 | European blue-chips up ahead of likely rate cuts | AN |
Smith & Nephew Plc specializes in designing, manufacturing and marketing medical products and equipment. Net sales break down by activity sector as follows:
- orthopedic surgery (39.9%): primarily orthopedic implants (hips, knees and shoulders);
- sports medicine, arthroscopy and cervicofacial surgery (31.2%): surgery and damaged tissue repair products and instruments, visualization products, etc.;
- wound care (28.9%): skin grafts for major burns victims, treatments for leg ulcers, etc.
The United States accounts for 53.7% of net sales.
Calendar
25/07/2024
- Q2 2024 Earnings Release (Projected)
Related indices
Trading Rating
Investor Rating
ESG Refinitiv
A-
Sell
Buy
Mean consensus
OUTPERFORM
Number of Analysts
17
Last Close Price
13.21
USD
Average target price
16.45
USD
Spread / Average Target
+24.58%
EPS Revisions
| 1st Jan change | Capi. | |
|---|---|---|
| -3.76% | 11.53B | |
| -4.86% | 8.33B | |
| +43.30% | 5.74B | |
| -22.44% | 4.65B | |
| +7.79% | 3.42B | |
| -17.26% | 2.63B | |
| -13.36% | 2.05B | |
| -16.39% | 1.9B | |
| -31.24% | 1.59B | |
| -8.10% | 1.18B |
- Stock Market
- Equities
- SN. Stock
- News Smith & Nephew Plc
- Smith & Nephew Names New CFO
